Development of doxorubicin loading platform based albumin-sporopollenin as drug carrier

dc.contributor.authorMaltas E.
dc.contributor.authorGubbuk I.H.
dc.contributor.authorYildiz S.
dc.date.accessioned2020-03-26T19:31:58Z
dc.date.available2020-03-26T19:31:58Z
dc.date.issued2016
dc.departmentSelçuk Üniversitesien_US
dc.description.abstractAlbumin is thought as an drug carrier for doxorubicin (DOX). The binding of doxorubicin to albumin was studied on the surface of sporopolleninin (SP) to produce a new drug system based natural materials. Human serum albumin (HSA) was immobilized on SPIONs in 20 mM Tris buffer, 7.4 of pH. Data showed that binding amount of HSA has been found to be as 285.53 ?g to the 25 mg of Sporopolleninin which also bounded 319.76 ?M of DOX. Binding of protein and drug to Sp were clarified by SEM, EDX and FT-IR analysis. © 2016.en_US
dc.description.sponsorshipBritish Association for Psychopharmacologyen_US
dc.description.sponsorshipWe would like to thank The Research Foundation of Selcuk University (BAP) for financial support of this work.en_US
dc.identifier.doi10.1016/j.bbrep.2016.06.012en_US
dc.identifier.endpage205en_US
dc.identifier.issn2405-5808en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage201en_US
dc.identifier.urihttps://dx.doi.org/10.1016/j.bbrep.2016.06.012
dc.identifier.urihttps://hdl.handle.net/20.500.12395/34266
dc.identifier.volume7en_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherElsevier B.V.en_US
dc.relation.ispartofBiochemistry and Biophysics Reportsen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.selcuk20240510_oaigen_US
dc.subjectDoxorubicinen_US
dc.subjectFluorescence spectroscopyen_US
dc.subjectMagnetic nanoparticlesen_US
dc.subjectProteinen_US
dc.titleDevelopment of doxorubicin loading platform based albumin-sporopollenin as drug carrieren_US
dc.typeArticleen_US

Dosyalar